Artificial Intelligence and the Future of Cancer Detection

At the International Symposium on Biomedical Imaging in Prague this past April, a Harvard-based artificial intelligence system won the Camelyon16 challenge, a competition comprised of participants introducing their individual AI system and its ability to facilitate automated lymph node metastasis diagnosis. Referred to as PathAl, the computing system identifies cancerous cells through deep learning--an algorithmic technique that accumulates copious amounts of unstructured data and organizes it into clusters before analyzing it for patterns. Deep learning is predominately used in speech recognition systems like Apple's Siri and Microsoft's Cortana. According to one of the challenge's organizers, Jeroen van der Laak of Radboud University Medical Center in Netherlands, the technology featured in the competition went "way beyond" his expectations, as the AI's accuracy proved strikingly close to that of human beings. In addition, van der Laak said AI technology has the propensity to intrinsically redefine the way histopathological images are handled in the medical community.